Fényes G, Tarjányi J, Ladvánszky C
Arzneimittelforschung. 1976;26(10a):1956-62.
Studies have been performed in a series of 44 neurosurgical cases. The patients were subjected to detailed neurological examination and EEG after admission and before being discharged. The effect of ethyl apovincaminate (RGH-4405, Cavinton) on cortical electric activity was investigated after the administration of 10 mg i.v. Cavinton. In cases on long-term courses of three times daily 5 mg Cavinton in tablets, control EEG was performed one and two months, respectively, after the start of medication. The state of vessels of the eye-ground was also checked. In cerebral angiography attention was concentrated on width of the vascular lumen and visualization of Cavinton effect on vessels which on account of narrowing or spasm had not filled up with contrast medium prior to Cavinton. During angiography the patients were given i.v. 10 mg. Cavinton diluted to 10 ml with physiological saline. In the cases where investigations failed to reveal any change requiring neurosurgical intervention and insufficient cerebral circulation had to be held responsible for the patient's condition, three times 10 mg Cavinton i.v. was administered daily as long as the patient was at our Department. After having been discharged these patients took three times daily 5 mg Cavinton in tablets. Duration of the course of oral Cavinton depended on the degree of improvement in the patient's condition. Cavinton was used with success in cases where cerebral circulation was damaged for functional or organic reasons. Allergic hypersensitivity did not occur in any of the cases, either on single doses or long-term use of parenteral or oral Cavinton.
对44例神经外科病例进行了研究。患者在入院时和出院前均接受了详细的神经学检查和脑电图检查。静脉注射10毫克长春乙酯(RGH - 4405,卡文通)后,研究了其对皮层电活动的影响。对于长期每日三次口服5毫克卡文通片的病例,分别在用药开始后的1个月和2个月进行对照脑电图检查。同时也检查了眼底血管的状况。在脑血管造影中,重点关注血管腔的宽度以及卡文通对因狭窄或痉挛而在使用卡文通前未被造影剂充盈的血管的作用。在血管造影过程中,给患者静脉注射用生理盐水稀释至10毫升的10毫克卡文通。对于那些检查未发现需要神经外科干预的变化且认为患者病情是由脑循环不足所致的病例,只要患者在本部门,就每日静脉注射三次10毫克卡文通。出院后,这些患者每日三次口服5毫克卡文通片。口服卡文通疗程的持续时间取决于患者病情的改善程度。在因功能性或器质性原因导致脑循环受损的病例中,卡文通使用成功。无论是单次剂量还是长期使用肠胃外或口服卡文通,均未出现任何过敏超敏反应。